The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers
Open Access
Abstract
Epigenetic aberrations, associated with altered DNA methylation profiles and global changes in the level of histone modifications, are commonly detected in head and neck squamous cell carcinomas (HNSCC). Recently, histone lysine demethylases have been implicated in the pathogenesis of HNSCC and emerged as potential molecular targets. Histone lysine demethylases (KDMs) catalyze the removal of methyl groups from lysine residues in histones. By affecting the methylation of H3K4, H3K9, H3K27, or H3K36, these enzymes take part in transcriptional regulation, which may result in changes in the level of expression of tumor suppressor genes and protooncogenes. KDMs are involved in many biological processes, including cell cycle control, senescence, DNA damage response, and heterochromatin formation. They are also important regulators of pluripotency. The overexpression of most KDMs has been observed in HNSCC, and their inhibition affects cell proliferation, apoptosis, cell motility, invasiveness, and stemness. Of all KDMs, KDM1, KDM4, KDM5, and KDM6 proteins are currently regarded as the most promising prognostic and therapeutic targets in head and neck cancers. The aim of this review is to present up-to-date knowledge on the significance of histone lysine demethylases in head and neck carcinogenesis and to discuss the possibility of using them as prognostic markers and pharmacological targets in patients’ treatment.Keywords
This publication has 78 references indexed in Scilit:
- Elevated Expression of Histone Demethylase PHF8 Associates with Adverse Prognosis in Patients of Laryngeal and Hypopharyngeal Squamous Cell CarcinomaEpigenomics, 2014
- High expression of the histone demethylase LSD1 associates with cancer cell proliferation and unfavorable prognosis in tongue cancerJournal of Oral Pathology & Medicine, 2014
- Histone demethylase Jumonji D3 (JMJD3/KDM6B) at the nexus of epigenetic regulation of inflammation and the aging processJournal of Molecular Medicine, 2014
- Genomic Analysis of Head and Neck Squamous Cell Carcinoma Cell Lines and Human Tumors: A Rational Approach to Preclinical Model SelectionMolecular Cancer Research, 2014
- JMJD2B Promotes Epithelial–Mesenchymal Transition by Cooperating with β-Catenin and Enhances Gastric Cancer MetastasisClinical Cancer Research, 2013
- Oncogenic Features of PHF8 Histone Demethylase in Esophageal Squamous Cell CarcinomaPLOS ONE, 2013
- Histone modification patterns correlate with patient outcome in oral squamous cell carcinomaCancer, 2013
- KDM4/JMJD2 Histone Demethylases: Epigenetic Regulators in Cancer CellsCancer Research, 2013
- Epigenetic Activation of AP1 Promotes Squamous Cell Carcinoma MetastasisScience Signaling, 2013
- The emerging roles for histone demethylases in the modulation of signaling pathwaysBioMolecular Concepts, 2012